Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?
about
Short chain fatty acids (butyrate) for induction of remission in ulcerative colitisCurrent level of consensus on probiotic science--report of an expert meeting--London, 23 November 2009Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel DiseasesClinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN)Probiotic yeasts: anti-inflammatory potential of various non-pathogenic strains in experimental colitis in miceSmall molecule immunomodulins from cultures of the human microbiome member Lactobacillus plantarum.Lactobacillus paracasei reduces intestinal inflammation in adoptive transfer mouse model of experimental colitis.Genotoxicity of Escherichia coli Nissle 1917 strain cannot be dissociated from its probiotic activity.Lessons from probiotic-host interaction studies in murine models of experimental colitis.Nutritional and probiotic supplementation in colitis models.The potential role of fecal microbiota transplantation in the treatment of inflammatory Bowel disease.Effects of a Lactobacillus reuteri BR11 mutant deficient in the cystine-transport system in a rat model of inflammatory bowel disease.Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition.Regulation of the polymeric immunoglobulin receptor in intestinal epithelial cells by Enterobacteriaceae: implications for mucosal homeostasis.Rebuilding the Gut Microbiota Ecosystem
P2860
Q24234780-F05BEC73-5E3C-410E-914B-AA578034C607Q24601092-CA1D8AB6-AE75-4D2E-A122-17A3C943E2DEQ26784194-B02D67D8-1981-44B2-80BD-9C1CF66EF51CQ33557634-1EE17819-17F9-4E78-9B1C-82303979DED4Q33830723-585D5A02-58B5-4359-B042-D4E9981588F6Q35054819-9661FFC8-847C-45CE-A6C4-F9D60B35F089Q35132967-E3311DC9-547F-4A1E-BC80-D10CF20DA7EFQ36392065-5873B0FB-A54A-4B4D-A94F-0845376ABDE9Q37907198-F3736ADF-258D-48C2-9929-B482EC33D438Q38021933-0B1636B6-F113-4290-A00D-9761369764B4Q38661453-25A301D8-F8BC-4438-9BDB-CE6248804948Q44023499-B5F8076A-EE04-4CE5-9E4B-342CDDA9AA48Q51614351-AE5F1725-FC4A-475F-97D8-FA1F8C50CD39Q54429291-6E3DC1C3-B437-4F14-97AD-7F135255A6A0Q58796769-BD407361-2B4A-4CDE-9F6D-E10C97EB8284
P2860
Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Is there any place for aliment ...... th inflammatory bowel disease?
@en
Is there any place for aliment ...... th inflammatory bowel disease?
@nl
type
label
Is there any place for aliment ...... th inflammatory bowel disease?
@en
Is there any place for aliment ...... th inflammatory bowel disease?
@nl
prefLabel
Is there any place for aliment ...... th inflammatory bowel disease?
@en
Is there any place for aliment ...... th inflammatory bowel disease?
@nl
P2860
P921
P356
P1476
Is there any place for aliment ...... th inflammatory bowel disease?
@en
P2093
Philippe Marteau
Xavier Dray
P2860
P304
P356
10.1002/MNFR.200700147
P577
2008-08-01T00:00:00Z